| Literature DB >> 29098462 |
Antonella Leggio1, Vanessa Leotta1, Emilia Lucia Belsito1, Maria Luisa Di Gioia1, Emanuela Romio1, Ilaria Santoro2, Domenico Taverna2, Giovanni Sindona2, Angelo Liguori3.
Abstract
This work compares the composition at different temperatures of gaseous phase of bergamot essential oil at equilibrium with the liquid phase. A new GC-MS methodology to determine quantitatively the volatile aroma compounds was developed. The adopted methodology involved the direct injection of headspace gas into injection port of GC-MS system and of known amounts of the corresponding authentic volatile compounds. The methodology was validated. This study showed that gaseous phase composition is different from that of the liquid phase at equilibrium with it.Entities:
Keywords: Aromatherapy; Bergamot; Essential oil; Gas chromatography–mass spectrometry; Gaseous phase; Volatile compounds
Year: 2017 PMID: 29098462 PMCID: PMC5668225 DOI: 10.1186/s13065-017-0340-y
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Composition of BEO and gaseous phase in equilibrium with the liquid at 0 °C
| Entry | Compound | Essential oil compositiona | Gaseous phase composition at 0 °C | |||
|---|---|---|---|---|---|---|
| tR (GC/MS) | GC–MS | GC–MS | GC–FID | tR (GC/FID) | ||
|
| ||||||
| 1 | α-Pinene | 6.14 | 1.03 ± 0.10 | 6.90 ± 0.10 | 7.06 ± 0.25 | 6.14 |
| 2 | β-Pinene | 8.19 | 6.56 ± 0.14 | 25.90 ± 0.40 | 26.68 ± 0.15 | 8.31 |
| 3 | α-Phellandrene | 9.48 | 0.04 ± 0.01 | – | – | – |
| 4 | α-Terpinene | 9.94 | 0.16 ± 0.02 | – | – | – |
| 5 | Limonene | 10.60 | 30.20 ± 0.77 | 58.07 ± 0.38 | 57.12 ± 0.35 | 10.48 |
| 6 |
| 11.19 | 0.18 ± 0.01 | 6.36 ± 0.04 | 6.02 ± 0.08 | 11.61 |
| 7 | γ-Terpinene | 12.15 | 11.95 ± 0.32 | – | – | – |
| 8 | Terpinolene | 13.36 | 0.27 ± 0.03 | – | – | – |
|
| ||||||
| 9 | Mircene | 8.72 | 0.82 ± 0.02 | 2.19 ± 0.22 | 2.16 ± 0.15 | 8.49 |
| 10 | Ocimene | 11.03 | 0.08 ± 0.01 | – | – | – |
|
| ||||||
| 11 | Linalool | 14.58 | 21.82 ± 0.87 | 3.04 ± 0.54 | 2.96 ± 0.33 | 14.55 |
| 12 | Linalyl acetate | 21.42 | 16.21 ± 0.84 | – | – | – |
| 13 | Neral | 22.94 | 0.21 ± 0.01 | – | – | – |
| 14 | Geranial | 24.46 | 0.11 ± 0.01 | – | – | – |
| 15 | Neryl acetate | 28.14 | 0.28 ± 0.02 | – | – | – |
|
| ||||||
| 16 | α-Terpineol | 20.01 | 0.87 ± 0.08 | – | – | – |
|
| ||||||
| 17 | Octyl acetate | 19.63 | 0.10 ± 0.01 | – | – | – |
|
| ||||||
| 18 | β-Caryophyllene | 27.85 | 0.14 ± 0.02 | – | – | – |
SD standard deviations
aThe w/w percentages were determined by the internal standard method and referred to the amount of each component contained in 100 g of essential oil
Stock solutions for the quantitative analysis at 0 °C
| Stock solutions F | Concentration for each analyte |
|---|---|
| Solution 1 | 0.015 |
| Solution 2 | 0.025 |
| Solution 3 | 0.050 |
| Solution 4 | 0.065 |
| Solution 5 | 0.075 |
| Solution 6 | 0.085 |
Fig. 1GC–MS analysis of the gaseous phase of bergamot essential oil at 0 °C (α-pinene tR = 6.14 min; β-pinene tR = 8.19 min; anisole tR = 8.42 min; mircene tR = 8.72 min; limonene tR = 10.60 min; p-cimene tR = 11.19 min; linalool tR = 14.58 min)
Fig. 2GC–FID analysis of the gaseous phase of bergamot essential oil at 0 °C (α-pinene tR = 6.14 min; β-pinene tR = 8.11 min; anisole tR = 8.31 min; mircene tR = 8.49 min; limonene tR = 10.48 min; p-cimene tR = 11.61 min; linalool tR = 14.55 min)
Composition of BEO and gaseous phase in equilibrium with the liquid at 0, 22 and 40 °C
| Entry | Compound | Essential oil compositiona | Gaseous phase composition at 0 °C | Gaseous phase composition at 22 °C | Gaseous phase composition at 40 °C | Biological activity |
|---|---|---|---|---|---|---|
| GC–MS | GC–MS | GC–MS | GC–MS | |||
|
| ||||||
| 1 | α-Pinene | 1.03 ± 0.10 | 6.90 ± 0.10 | 5.38 ± 0.10 | 1.29 ± 0.03 | Anticancer [ |
| 2 | β-Pinene | 6.56 ± 0.14 | 25.90 ± 0.40 | 19.69 ± 0.31 | 7.10 ± 0.05 | Anti-depressant [ |
| 3 | α-Phellandrene | 0.04 ± 0.01 | – | 0.27 ± 0.02 | 0.39 ± 0.02 | Anti-proliferative [ |
| 4 | α-Terpinene | 0.16 ± 0.02 | – | 0.27 ± 0.01 | 0.18 ± 0.02 | Antioxidant [ |
| 5 | Limonene | 30.20 ± 0.77 | 58.07 ± 0.38 | 47.27 ± 0.28 | 37.15 ± 0.29 | Anti-inflammatory [ |
| 6 |
| 0.18 ± 0.01 | 6.36 ± 0.04 | 0.62 ± 0.03 | 0.49 ± 0.01 | Anti-inflammatory [ |
| 7 | γ-Terpinene | 11.95 ± 0.32 | – | 13.13 ± 0.29 | 12.22 ± 0.1 | Antibacterial [ |
| 8 | Terpinolene | 0.27 ± 0.03 | – | – | – | |
|
| ||||||
| 9 | Mircene | 0.82 ± 0.02 | 2.19 ± 0.22 | 1.42 ± 0.036 | 0.84 ± 0.02 | Analgesic [ |
| 10 | Ocimene | 0.08 ± 0.01 | – | – | – | |
|
| ||||||
| 11 | Linalool | 21.82 ± 0.87 | 3.04 ± 0.54 | 9.71 ± 0.18 | 27.52 ± 0.24 | Anti-inflammatory [ |
| 12 | Linalyl acetate | 16.21 ± 0.84 | – | 0.66 ± 0.03 | 10.40 ± 0.08 | Anti-inflammatory [ |
| 13 | Neral | 0.21 ± 0.01 | – | – | – | |
| 14 | Geranial | 0.11 ± 0.01 | – | – | – | |
| 15 | Neryl acetate | 0.28 ± 0.02 | – | – | – | |
|
| ||||||
| 16 | α-Terpineol | 0.87 ± 0.08 | – | – | – | |
|
| ||||||
| 17 | Octyl acetate | 0,10 ± 0.01 | – | – | 1.91 ± 0.04 | Anti-inflammatory [ |
|
| ||||||
| 18 | β-Caryophyllene | 0.14 ± 0.02 | – | – | – | |
SD standard deviations
aThe w/w percentages were determined by the internal standard method and referred to the amount of each component contained in 100 g of essential oil
Stock solutions for the quantitative analysis at 22 and 40 °C
| Quantitative analysis at 22 °C | Quantitative analysis at 40 °C | ||
|---|---|---|---|
| Stock solutions J | Concentration or each analyte (mg/mL) | Stock solutions P | Concentration for each analyte (mg/mL) |
| Solution 1 | 0.002 | Solution 1 | 0.001 |
| Solution 2 | 0.004 | Solution 2 | 0.002 |
| Solution 3 | 0.006 | Solution 3 | 0.004 |
| Solution 4 | 0.008 | Solution 4 | 0.006 |
| Solution 5 | 0.010 | Solution 5 | 0.008 |
| Solution 6 | 0.015 | Solution 6 | 0.010 |